Adler M. A., & Posner E. A. (2006). New foundations for benefit-cost analysis. Cambridge, MA: Harvard University Press.
Alberini A., & Kahn J. R. (Eds.) (2006). Handbook on contingent valuation. Cheltenham UK and Northampton MA: Edward Elgar.
Aldy J. E., & Viscusi W. K. (2007). Age differences in the value of statistical life: revealed preference evidence. Review of Environmental Economics and Policy
Arias E. (2010). United States life tables, (2006). National Vital Statistics Reports
58(21). Centers for Disease Control and Prevention, U.S. Department of Health and Human Services.
Bateman I. J., Carson R.T., Day B., Hanemann M., Hanley N., Hett T., et al. (2002). Economic valuation with stated preference techniques. Cheltenham UK and Northampton MA: Edward Elgar.
Bergstrom T. C. (1982). When is a man’s life worth more than his human capital? In: Jones-Lee M. (Ed.), The value of life and safety. Amsterdam: North Holland.
Bergstrom T. C. (2006). Benefit-cost in a benevolent society. American Economic Review
Blomquist G. (2004). Self-protection and averting behavior, values of statistical lives, and benefit cost analysis of environmental policy. Review of the Economics of the Household
Boardman A. E., Greenberg D. H., Vining A. R., & Weimer D. L.. (2011). Cost-benefit analysis: concepts and practices. Upper Saddle River, NJ: Pearson.
Bosworth R., Cameron T. A., & DeShazo J. R. (2010). Is an ounce of prevention worth a pound of cure? comparing demand for public prevention and treatment policies. Medical Decision Making
Cameron T. A. (2010). Euthanizing the value of a statistical life. Review of Environmental Economics and Policy
Carson R. T. (2012). Contingent valuation: a comprehensive bibliography and history. Cheltenham UK and Northampton MA: Edward Elgar.
Champ P. A., Boyle K. J., & Brown T. C. (Eds.) (2003). A primer on non-market valuation. Boston MA: Kluwer Academic Press.
Cropper M., Hammitt J. K., & Robinson L. A. (2011). Valuing mortality risk reductions: progress and challenges. Annual Review of Resource Economics
Cropper M., & Morgan M. G. (2007). SAB Advisory on EPA’s issues in valuing mortality risk reduction. Memorandum to EPA Administrator Stephen L. Johnson from the EPA Science Advisory Board and Environmental Economics Advisory Committee. (EPA-SAB-08-001.)
European Commission. (2009). Impact Assessment Guidelines. SEC(2009) 92.
Finkelstein E. A., Corso P. S., & Miller T. R. (2006). The incidence and economic burden of injuries in the United States. Oxford and New York: Oxford University Press.
Freeman A. M. III. (2003). The measurement of environmental and resource values: theory and methods (2nd ed.),
Washington D. C.: Resources for the Future.
Grosse S. D., Krueger K. V., & Mvundura M. (2009). Economic productivity by age and sex: 2007 estimates for the United States. Medical Care
Hammitt J. K. (2000). Valuing mortality risk: theory and practice. Environmental Science and Technology
Hammitt J. K. (2002). QALYs versus WTP. Risk Analysis
Hammitt J. K. (2007). Valuing changes in mortality risk: lives saved versus life years saved. Review of Environmental Economics and Policy
Hammitt J. K. (2009). Response: saving lives: benefit-cost analysis and distribution. University of Pennsylvania Law Review PENNumbra
Hammitt J. K., & Robinson L. A. (2011). The income elasticity of the value per statistical life: transferring estimates between high and low income populations. Journal of Benefit-Cost Analysis
2, Art. 1.
Hanemann W. M. (1991). Willingness to pay and willingness to accept: how much can they differ?
American Economic Review
Haninger K., & Hammitt J. K. (2011). Diminishing willingness to pay per quality-adjusted life year: valuing acute foodborne illness. Risk Analysis
Hirth R. A., Chernew M. E., Miller E., Fendrick A. M., & Weissert W. G. (2000). Willingness to pay for a quality-adjusted life year: in search of a standard. Medical Decision Making
HM Treasury. (2003). The green book: appraisal and evaluation in central government. London: TSO. (Includes 2011 updates.)
Horowitz J. K., & McConnell K. E. (2002). A review of WTA/WTP Studies. Journal of Environmental Economics and Management
Hunt A., & Ferguson J. (2010). A review of recent policy-relevant findings from the environmental health literature. Prepared for the Organisation for Economic Co-Operation and Development. ENV/EPOC/WPNEP(2009)9/FINAL.
Institute of Medicine. (2006). Valuing health for regulatory cost-effectiveness analysis. In: Miller W., Robinson L. A. & Lawrence R. S.. (Eds.), Washington, D.C.: The National Academies Press.
Johnson F. R., Fries E. E., & Banzhaf H. S. (1997). Valuing morbidity: an integration of the willingness-to-pay and health-status index literatures. Journal of Health Economics
Jones-Lee M. W. (1991). Altruism and the value of other people’s safety. Journal of Risk and Uncertainty
Kahneman D., Knetsch J. L., & Thaler R. H. (1991). Anomalies: the endowment effect, loss aversion, and status quo bias. Journal of Economic Perspectives
Kling C. L., & Swackhamer D. L. (2011). Review of ‘valuing mortality risk reductions for environmental policy: a white paper’ (December 10, 2010). Memorandum to Lisa P. Jackson, EPA Administrator from the EPA Science Advisory Board and Environmental Economics Advisory Committee. EPA-SAB-11-011.
Knetsch J. L. (2010). Values of gains and losses: reference states and choices of measure. Environment and Resource Economics
Krupnick A. (2007). Mortality-risk valuation and age: stated preference evidence. Review of Environmental Economics and Policy
Lipscomb J., Drummond M., Fryback D., Gold M., & Revicki D. (2009). Retaining, and enhancing, the QALY. Value in Health
12(Supp. 1), S18–S26.
Lindhjem H., Navrud S., Braathen N. A., & Biausque V. (2011). Valuing mortality risk reductions from environmental, transport, and health policies: a global meta-analysis of stated preference studies. Risk Analysis
Lund J. L., Yabroff K. R., Ibuka Y., Russell L. B., Barnett P. G., Lipscomb J., ... Brown M. L. (2009). Inventory of data sources for estimating health care costs in the United States. Medical Care
Murray C. J. L., & Lopez A. D. (Eds.) (1996). The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Cambridge: Harvard University Press.
National Academies. (2008). Estimating mortality risk reduction and economic benefits from controlling ozone air pollution. Committee on estimating mortality risk reduction benefits from decreasing tropospheric ozone exposure. Washington, D.C.: National Academies Press.
NERA Economic Consulting. (2011). Updating the VPF and VPIs: phase 1: final report. Prepared for the United Kingdom Department for Transport.
Organisation for Economic Co-operation and Development. (2012). Mortality risk valuation in environment, health and transport policies. Paris: OECD Publishing.
Robinson L. A. (2007). How U.S. government agencies value mortality risk reductions. Review of Environmental Economics and Policy
Robinson L. A. (2009). Valuing lives, valuing risks, and respecting preferences in regulatory analysis. Regulation and Governance
Robinson L. A., & Hammitt J. K. (2011a). Valuing health and longevity in regulatory analysis: current issues and challenges. In: Levi-Faur D. (Ed.), The handbook of the politics of regulation. Cheltenham and Northampton: Edward Elgar.
Robinson L. A., & Hammitt J. K. (2011b). Behavioral economics and the conduct of benefit-cost analysis: towards principles and standards. Journal of Benefit-Cost Analysis
2(2), Art. 5.
Shaw J. W., Johnson J. A., & Coons S. J. (2005). US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Medical Care
Sullivan P. W., & Ghushchyan V. (2006). Preference-based EQ-5D index scores for chronic conditions in the United States. Medical Decision Making
Svensson M., & Johansson M. V. (2010). Willingness to pay for private and public road safety in stated preference studies: why the difference?
Accident Analysis and Prevention
Thorat T., Cangelosi M., & Neumann P. J. (2012). Skills of the trade: the Tufts cost-effectiveness analysis registry. Journal of Benefit-Cost Analysis
3(1), Art. 1.
Treasury Board of Canada, Secretariat. (2007). Canadian cost-benefit analysis guide: regulatory proposals (Interim).
Tversky A., & Kahneman D. (1974). Judgment under uncertainty: heuristics and biases. Science
US Department of Transportation. (2011). Treatment of the economic value of a statistical life in departmental analyses – 2011 interim adjustment. Memorandum to Secretarial Officers and Modal Administrators from P. Trottenberg, Assistant Secretary For Transportation Policy, and R. Rivkin, General Counsel.
US Environmental Protection Agency. (2010a). Valuing mortality risk reductions for environmental policy: a white paper (Review Draft). Prepared by the National Center for Environmental Economics for consultation with the Science Advisory Board – Environmental Economics Advisory Committee.
US Environmental Protection Agency. (2010b). Guidelines for preparing economic analysis. EPA 240-R-10-001.
US Office of Management and Budget. (2003). Circular A-4: regulatory analysis.
Van Houtven G., Powers J., Jessup A., & Yang J.-C. (2006). Valuing avoided morbidity using meta-regression analysis: what can health status measures and QALYs tell us about WTP?
Viscusi W. K., & Aldy J. E. (2003). The value of a statistical life: a critical review of market estimates throughout the world. Journal of Risk and Uncertainty
Viscusi W. K. (2009). The devaluation of life. Regulation and governance
Willig R. D. (1976). Consumer’s surplus without apology. The American Economic Review
Yabroff K. R., Brown M. L., Lawrence W. F., Barnett P. G., & Lipscomb J. (Eds.). (2009). Health care costing: data, methods, future directions. Medical Care
47(7), Supplement 1.
Zeckhauser R., & Shepard D. (1976). Where now for saving lives?
Law and Contemporary Problems